Business Context and Reporting Period
Company: Horizon Technology Finance Corp (HRZN)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2012
Business Overview: An externally managed, non-diversified, closed-end investment company regulated as a Business Development Company (BDC) and taxed as a Regulated Investment Company (RIC). The Company primarily makes secured loans to development-stage companies in technology, life science, healthcare information and services, and cleantech industries.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2012 | Six Months Ended June 30, 2011 |
|---|---|---|
| Total Investment Income | $12.1 million | $11.4 million |
| Net Investment Income | $5.6 million | $4.2 million |
| Net Realized (Loss) Gain | ($0.1 million) | $5.6 million |
| Net Unrealized Depreciation | ($0.8 million) | ($2.3 million) |
| Net Increase in Net Assets from Operations | $4.8 million | $7.5 million |
| Net Asset Value (NAV) per Share | $16.73 | $17.40 |
| Total Assets | $209.8 million | $197.8 million (Dec 31, 2011) |
| Total Borrowings | $80.4 million | $64.6 million (Dec 31, 2011) |
| Cash and Money Market Funds | $7.5 million | $14.8 million (Dec 31, 2011) |
Material Changes vs. Prior Period
- Investment Income: Increased 5.9% year-over-year for the six-month period, driven by an increased average loan portfolio size, despite lower yields on average loans (14.1% vs. 14.6%).
- Expenses: Total expenses decreased 10.1% to $6.5 million. This reduction was primarily due to lower performance-based incentive fees ($1.3 million vs. $2.1 million) and lower management fees due to deleveraging, partially offset by higher interest expense from new Senior Notes and Wells Facility borrowings.
- Realized Gains/Losses: The Company recognized a net realized loss of $0.1 million, a significant shift from the $5.6 million realized gain in the prior year period. The loss was primarily due to the charge-off of warrants in one portfolio company.
- Portfolio Composition: The portfolio grew to $195.6 million (fair value) from $178.0 million at year-end 2011. Life Science remains the largest sector (49.8%), followed by Technology (44.4%).
- Debt Structure: Borrowings increased to $80.4 million. The Company issued $33 million in 7.375% Senior Notes in March/April 2012 and increased utilization of the Wells Facility, while continuing to pay down the WestLB Facility.
Guidance, Outlook, and Risks
- Capital Raising: On July 23, 2012 (subsequent to period end), the Company completed a public offering of approximately 1.9 million shares for gross proceeds of $30.9 million.
- Dividends: The Company declared a second-quarter dividend of $0.45 per share on August 3, 2012. The Company intends to distribute at least 90% of taxable income to maintain RIC status.
- Liquidity: As of June 30, 2012, the Company had approximately $42.1 million of available borrowing capacity under the Wells Facility. Cash and money market funds totaled $7.5 million.
- Asset Quality: The weighted average credit rating of the loan portfolio improved to 3.3 (on a scale of 1-4, where 4 is best) from 3.1 at year-end 2011. There were no loans on non-accrual status.
- Risks: Key risks include interest rate volatility (floating rate debt vs. fixed rate assets), the ability of portfolio companies to repay loans, and the impact of market conditions on the valuation of Level 3 assets (warrants and private debt).
Investor Verification Checklist
- Debt Maturity Profile: Verify the amortization schedule of the WestLB Facility (maturing 2015) and Wells Facility (maturing 2017) against projected cash flows.
- Warrant Valuation: Review the assumptions used for Level 3 warrant valuations (volatility, discount rates) given the significant unrealized depreciation in the period.
- Concentration Risk: Confirm that the five largest loans (representing ~27% of the portfolio) remain performing and that no single loan exceeds 10% of total loans.
- Asset Coverage Ratio: Verify the current asset coverage ratio (256% as of June 30, 2012) to ensure compliance with the 200% minimum requirement under the 1940 Act.
- Subsequent Equity Offering: Assess the impact of the $30.9 million equity raise completed in July 2012 on future leverage ratios and investment capacity.